Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
Crossref DOI link: https://doi.org/10.1186/s40880-017-0208-5
Published Online: 2017-05-10
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Altundag, Kadri https://orcid.org/0000-0003-3357-0096
